Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S.

Arch Neurol. 2006 Nov;63(11):1551-5.

PMID:
17101823
2.

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.

3.

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA.

Arch Intern Med. 2003 May 12;163(9):1053-7.

PMID:
12742802
4.

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.

Arch Neurol. 2008 Jan;65(1):89-93. doi: 10.1001/archneurol.2007.29.

PMID:
18195144
5.

Thyroid function and the risk of Alzheimer disease: the Framingham Study.

Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, Wolf PA, Seshadri S.

Arch Intern Med. 2008 Jul 28;168(14):1514-20. doi: 10.1001/archinte.168.14.1514.

6.

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.

Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B; REAL.FR Study Group.

Neurology. 2009 Oct 27;73(17):1359-66. doi: 10.1212/WNL.0b013e3181bd80e9.

PMID:
19858457
7.

Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study.

Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, Chiang CH, Huang PH, Chen TJ, Lin SJ, Chen JW, Chan WL.

PLoS One. 2014 Jan 29;9(1):e87095. doi: 10.1371/journal.pone.0087095. eCollection 2014.

8.

Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

Wilson RS, Mendes De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA.

JAMA. 2002 Feb 13;287(6):742-8.

PMID:
11851541
9.

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA.

N Engl J Med. 2002 Feb 14;346(7):476-83.

10.

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, Wolf PA, Vasan RS, Seshadri S.

Neurology. 2014 May 6;82(18):1613-9. doi: 10.1212/WNL.0000000000000382. Epub 2014 Apr 4.

11.

The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.

Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Berry-Kravis E, Bennett DA.

Neurocase. 2005 Feb;11(1):3-7.

PMID:
15804918
12.

Dementia and Alzheimer disease incidence: a prospective cohort study.

Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB.

Arch Neurol. 2002 Nov;59(11):1737-46.

PMID:
12433261
13.

Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders.

Profenno LA, Porsteinsson AP, Faraone SV.

Biol Psychiatry. 2010 Mar 15;67(6):505-12. doi: 10.1016/j.biopsych.2009.02.013. Epub 2009 Apr 9.

PMID:
19358976
14.

Reproductive period and risk of dementia in postmenopausal women.

Geerlings MI, Ruitenberg A, Witteman JC, van Swieten JC, Hofman A, van Duijn CM, Breteler MM, Launer LJ.

JAMA. 2001 Mar 21;285(11):1475-81.

PMID:
11255424
15.

Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus.

Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV; Health ABC Study.

JAMA Intern Med. 2013 Jul 22;173(14):1300-6. doi: 10.1001/jamainternmed.2013.6176.

16.

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

Arch Intern Med. 2006 Nov 13;166(20):2191-201.

PMID:
17101936
17.

Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.

Wang KC, Woung LC, Tsai MT, Liu CC, Su YH, Li CY.

Neuroepidemiology. 2012;38(4):237-44. doi: 10.1159/000337428. Epub 2012 May 5.

18.

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG.

Arch Neurol. 2007 Mar;64(3):354-62. Erratum in: Arch Neurol. 2007 Sep;64(9):1246.

PMID:
17353377
19.

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.

Arch Neurol. 2006 Nov;63(11):1545-50.

PMID:
17101822
20.

The Association Between Diabetes and Dementia Among Elderly Individuals: A Nationwide Inpatient Sample Analysis.

Sherzai D, Sherzai A, Lui K, Pan D, Chiou D, Bazargan M, Shaheen M.

J Geriatr Psychiatry Neurol. 2016 May;29(3):120-5. doi: 10.1177/0891988715627016. Epub 2016 Feb 9.

Supplemental Content

Support Center